ATM Health news
News
Medical news and safety updates written for patients and for clinicians. These articles are general information. They are not personal medical advice and do not replace care from your own clinician.
-
Vitamin B6 in listed medicines: TGA consults on label statement and 2 mg warning threshold
TGA consultation (closes 25 November 2026) on a standardised B6 label statement, a stronger neuropathy warning above 2 mg/day and infant restrictions, ahead of Schedule 3 changes from 1 June 2027.
-
TGA proposes clearer labels and stronger warnings for vitamin B6 supplements
The TGA is consulting until 25 November 2026 on clearer vitamin B6 labels and stronger nerve-damage warnings. What is proposed, what is already decided, and what it means for you.
-
TGA extends Estradot and Estraderm MX 100 HRT patch shortage dates: clinician summary
TGA 11 November 2026 update: Estradot 25–100 shortage now to 30 June 2027 and Estraderm MX 100 to 30 November 2026; substitution instrument, PBS and prescribing points.
-
HRT patch shortage update: Estradot supply now expected to recover by mid-2027
The TGA has extended its estimated shortage of several Estradot HRT patch strengths to 30 June 2027. Here is what changed, how pharmacist substitution works and what to keep in mind.
-
T-REx RCT: resistance training attenuates lean mass loss and preserves strength on tirzepatide — clinician summary
Nature Medicine RCT (n=120, 40 weeks): supervised resistance training with tirzepatide reduced DXA lean soft tissue loss by 1.09 kg and increased strength, with similar weight and fat loss. Methods, harms and limitations.
-
Weight training reduced muscle loss and improved strength during tirzepatide treatment, Australian trial finds
A 40-week Australian randomised trial found supervised resistance training alongside tirzepatide reduced lean tissue loss by about 1.1 kg and improved strength, with similar weight loss. What it means and its limits.
-
ACSQHC draft virtual care standards: consultation open — Clinicians
National draft virtual-care standards are open for comment until 13 December 2026; intended across primary care and other remote-care settings.
-
Draft national virtual care standards open for public comment — Patients
Australia’s safety commission is consulting on draft standards for telehealth and other remote care until 13 December 2026.
-
Bicillin L-A shortage: supply, alternatives and safety checks — Clinicians
TGA advice on conserving paediatric stock, section 19A alternatives, product-specific preparation and allergen checks during the ongoing shortage.
-
Bicillin L-A shortage: updated Australian supply advice — Patients
The TGA’s updated advice on an ongoing injectable antibiotic shortage, overseas alternatives and the need for individual suitability assessment.